Ignite Creation Date:
2024-05-06 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03552029
Status:
TERMINATED
Last Update Posted:
2022-05-20
First Post:
2018-05-17
Brief Title:
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia AML
Sponsor:
Organization:
Daiichi Sankyo